Poly Interest Expense vs Total Operating Expenses Analysis

POLYMED Stock

2,692 72.10 2.61%

Poly Medicure financial indicator trend analysis is much more than just breaking down Poly Medicure Limited prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Poly Medicure Limited is a good investment. Please check the relationship between Poly Medicure Interest Expense and its Total Operating Expenses accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Poly Medicure Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Interest Expense vs Total Operating Expenses

Interest Expense vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Poly Medicure Limited Interest Expense account and Total Operating Expenses. At this time, the significance of the direction appears to have weak relationship.

The correlation between Poly Medicure's Interest Expense and Total Operating Expenses is 0.34. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Poly Medicure Limited, assuming nothing else is changed. The correlation between historical values of Poly Medicure's Interest Expense and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of Poly Medicure Limited are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Interest Expense i.e., Poly Medicure's Interest Expense and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.34

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most indicators from Poly Medicure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Poly Medicure Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Poly Medicure Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

The current year's Selling General Administrative is expected to grow to about 2.6 B, whereas Tax Provision is forecasted to decline to about 446.7 M.

	2021	2022	2023	2024 (projected)
Interest Expense	37.2M	88.4M	130.5M	83.2M
Depreciation And Amortization	538.7M	571.2M	639.3M	671.2M

Interest Expense Depreciation And Amortization

Poly Medicure fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Accounts Payable	Good Will	Retained Earnings	Current Deferred Revenue	Short Term Investments
Total Assets		0.63	0.88	0.97	1.0	0.98	0.19	0.69	0.99	0.48	0.91	0.95	0.92	0.08	0.99	0.08	0.91	0.75	0.99	0.96	0.66	0.85	0.29	0.98	0.11	0.71
Short Long Term Debt Total	0.63		0.51	0.66	0.57	0.58	0.77	0.2	0.63	0.16	0.5	0.69	0.38	0.69	0.65	-0.03	0.4	0.94	0.61	0.63	0.88	0.83	0.42	0.55	-0.5	0.47
Other Current Liab	0.88	0.51		0.93	0.88	0.93	0.05	0.73	0.92	0.64	0.69	0.88	0.88	-0.07	0.91	-0.05	0.81	0.64	0.83	0.92	0.43	0.71	0.26	0.92	0.08	0.45
Total Current Liabilities	0.97	0.66	0.93		0.95	0.98	0.18	0.75	0.99	0.55	0.79	0.93	0.91	0.13	0.98	0.11	0.85	0.78	0.93	0.99	0.64	0.83	0.36	0.97	0.0	0.56
Total Stockholder Equity	1.0	0.57	0.88	0.95		0.97	0.14	0.7	0.98	0.47	0.92	0.94	0.93	0.01	0.98	0.08	0.93	0.71	0.99	0.94	0.62	0.82	0.25	0.98	0.18	0.73
Property Plant And Equipment Net	0.98	0.58	0.93	0.98	0.97		0.08	0.81	1.0	0.59	0.81	0.93	0.92	0.03	0.98	0.07	0.91	0.7	0.93	0.99	0.57	0.77	0.26	1.0	0.08	0.56
Net Debt	0.19	0.77	0.05	0.18	0.14	0.08		-0.41	0.14	-0.23	0.22	0.3	-0.03	0.81	0.22	-0.17	-0.05	0.62	0.24	0.13	0.68	0.5	0.26	0.05	-0.55	0.41
Cash	0.69	0.2	0.73	0.75	0.7	0.81	-0.41		0.78	0.65	0.44	0.62	0.7	-0.17	0.68	0.16	0.75	0.32	0.59	0.8	0.17	0.35	0.12	0.8	0.1	0.07
Non Current Assets Total	0.99	0.63	0.92	0.99	0.98	1.0	0.14	0.78		0.55	0.83	0.94	0.91	0.09	0.99	0.08	0.9	0.74	0.95	0.99	0.62	0.8	0.28	0.99	0.04	0.59
Non Currrent Assets Other	0.48	0.16	0.64	0.55	0.47	0.59	-0.23	0.65	0.55		0.22	0.55	0.5	-0.11	0.49	-0.14	0.59	0.27	0.39	0.57	0.2	0.26	0.29	0.57	0.23	-0.03
Cash And Short Term Investments	0.91	0.5	0.69	0.79	0.92	0.81	0.22	0.44	0.83	0.22		0.83	0.82	-0.01	0.87	0.06	0.84	0.63	0.96	0.75	0.61	0.8	0.21	0.83	0.3	0.93
Net Receivables	0.95	0.69	0.88	0.93	0.94	0.93	0.3	0.62	0.94	0.55	0.83		0.87	0.19	0.95	-0.17	0.89	0.76	0.93	0.9	0.64	0.83	0.26	0.93	-0.02	0.66
Common Stock Shares Outstanding	0.92	0.38	0.88	0.91	0.93	0.92	-0.03	0.7	0.91	0.5	0.82	0.87		-0.17	0.93	0.09	0.87	0.56	0.9	0.89	0.44	0.72	0.22	0.94	0.25	0.61
Non Current Liabilities Total	0.08	0.69	-0.07	0.13	0.01	0.03	0.81	-0.17	0.09	-0.11	-0.01	0.19	-0.17		0.09	-0.11	-0.11	0.46	0.07	0.11	0.59	0.26	0.24	-0.01	-0.71	0.05
Inventory	0.99	0.65	0.91	0.98	0.98	0.98	0.22	0.68	0.99	0.49	0.87	0.95	0.93	0.09		0.07	0.88	0.77	0.97	0.97	0.66	0.87	0.31	0.98	0.07	0.68
Other Current Assets	0.08	-0.03	-0.05	0.11	0.08	0.07	-0.17	0.16	0.08	-0.14	0.06	-0.17	0.09	-0.11	0.07		-0.03	0.11	0.08	0.14	0.2	0.12	0.41	0.07	0.22	0.04
Other Stockholder Equity	0.91	0.4	0.81	0.85	0.93	0.91	-0.05	0.75	0.9	0.59	0.84	0.89	0.87	-0.11	0.88	-0.03		0.52	0.89	0.85	0.45	0.64	0.15	0.93	0.28	0.62
Total Liab	0.75	0.94	0.64	0.78	0.71	0.7	0.62	0.32	0.74	0.27	0.63	0.76	0.56	0.46	0.77	0.11	0.52		0.74	0.74	0.91	0.95	0.53	0.68	-0.25	0.58
Total Current Assets	0.99	0.61	0.83	0.93	0.99	0.93	0.24	0.59	0.95	0.39	0.96	0.93	0.9	0.07	0.97	0.08	0.89	0.74		0.9	0.68	0.86	0.29	0.94	0.18	0.82
Short Term Debt	0.96	0.63	0.92	0.99	0.94	0.99	0.13	0.8	0.99	0.57	0.75	0.9	0.89	0.11	0.97	0.14	0.85	0.74	0.9		0.6	0.78	0.31	0.98	-0.02	0.5
Common Stock	0.66	0.88	0.43	0.64	0.62	0.57	0.68	0.17	0.62	0.2	0.61	0.64	0.44	0.59	0.66	0.2	0.45	0.91	0.68	0.6		0.86	0.52	0.55	-0.16	0.63
Accounts Payable	0.85	0.83	0.71	0.83	0.82	0.77	0.5	0.35	0.8	0.26	0.8	0.83	0.72	0.26	0.87	0.12	0.64	0.95	0.86	0.78	0.86		0.48	0.77	-0.03	0.75
Good Will	0.29	0.42	0.26	0.36	0.25	0.26	0.26	0.12	0.28	0.29	0.21	0.26	0.22	0.24	0.31	0.41	0.15	0.53	0.29	0.31	0.52	0.48		0.23	0.01	0.19
Retained Earnings	0.98	0.55	0.92	0.97	0.98	1.0	0.05	0.8	0.99	0.57	0.83	0.93	0.94	-0.01	0.98	0.07	0.93	0.68	0.94	0.98	0.55	0.77	0.23		0.12	0.59
Current Deferred Revenue	0.11	-0.5	0.08	0.0	0.18	0.08	-0.55	0.1	0.04	0.23	0.3	-0.02	0.25	-0.71	0.07	0.22	0.28	-0.25	0.18	-0.02	-0.16	-0.03	0.01	0.12		0.31
Short Term Investments	0.71	0.47	0.45	0.56	0.73	0.56	0.41	0.07	0.59	-0.03	0.93	0.66	0.61	0.05	0.68	0.04	0.62	0.58	0.82	0.5	0.63	0.75	0.19	0.59	0.31

Click cells to compare fundamentals

Poly Medicure Account Relationship Matchups

Poly Medicure fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	7.7B	12.2B	13.8B	15.8B	18.6B	19.5B
Short Long Term Debt Total	2.1B	1.4B	1.3B	1.5B	1.7B	975.7M
Other Current Liab	407.5M	292.3M	364.5M	699.8M	710.7M	746.2M
Total Current Liabilities	2.0B	1.7B	2.3B	2.9B	3.5B	3.7B
Total Stockholder Equity	4.3B	9.7B	10.9B	12.4B	14.7B	15.4B
Property Plant And Equipment Net	3.3B	3.9B	4.8B	6.6B	8.9B	9.3B
Net Debt	2.0B	1.3B	1.2B	1.4B	272.9M	259.3M
Cash	48.6M	49.5M	77.6M	70.6M	1.5B	1.5B
Non Current Assets Total	4.5B	5.2B	5.9B	7.7B	10.2B	10.7B
Non Currrent Assets Other	195.1M	1K	81.1M	378.1M	465.7M	489.0M
Cash And Short Term Investments	409.7M	3.7B	3.5B	3.1B	2.9B	3.0B
Net Receivables	1.3B	1.6B	2.1B	2.4B	2.7B	2.8B
Common Stock Shares Outstanding	88.3M	89.2M	96.0M	96.0M	96.0M	98.7M
Liabilities And Stockholders Equity	7.7B	12.2B	13.8B	15.8B	18.6B	19.5B
Non Current Liabilities Total	1.4B	867.6M	626.8M	422.8M	373.8M	651.6M
Inventory	1.1B	1.3B	1.7B	2.1B	2.2B	2.3B
Other Current Assets	376.0M	475.0M	567.7M	366.2M	646.7M	418.7M
Other Stockholder Equity	6.9M	3.9B	3.9B	3.9B	6.8B	7.1B
Total Liab	3.3B	2.6B	2.9B	3.4B	3.9B	2.0B
Total Current Assets	3.2B	7.1B	7.8B	8.1B	8.4B	8.8B
Accumulated Other Comprehensive Income	(2.3B)	2.2B	2.5B	2.7B	115.4M	121.2M
Short Term Debt	889.3M	721.8M	882.0M	1.3B	1.7B	1.8B
Common Stock	441.2M	479.4M	479.5M	479.7M	479.9M	302.5M
Accounts Payable	663.6M	645.2M	890.4M	923.1M	956.0M	526.0M
Retained Earnings	1.9B	3.0B	4.0B	5.3B	7.3B	7.7B
Current Deferred Revenue	(889.3M)	346.9M	263.7M	379.8M	100.4M	105.4M
Short Term Investments	361.1M	3.7B	3.4B	3.0B	1.3B	1.2B
Intangible Assets	234.1M	228.3M	220.7M	215.5M	249.9M	206.7M
Other Liab	276.1M	215.3M	215.2M	241.7M	277.9M	231.0M
Net Tangible Assets	3.3B	3.8B	9.1B	10.4B	11.9B	12.5B
Other Assets	399.5M	246.6M	453.6M	378.1M	434.9M	289.7M
Long Term Debt	1.1B	632.8M	381.3M	175.0M	10.9M	10.3M
Short Long Term Debt	917.2M	388.2M	871.5M	1.3B	1.7B	1.8B
Property Plant Equipment	3.3B	3.9B	4.8B	6.6B	7.6B	8.0B
Long Term Debt Total	1.1B	652.4M	385.1M	188.5M	169.7M	161.2M
Capital Surpluse	6.9M	3.9B	3.9B	3.9B	4.5B	4.7B
Non Current Liabilities Other	24.7M	607K	(1K)	1K	900.0	855.0

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Other Information on Investing in Poly Stock

Balance Sheet is a snapshot of the financial position of Poly Medicure Limited at a specified time, usually calculated after every quarter, six months, or one year. Poly Medicure Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Poly Medicure and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Poly currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Poly Interest Expense vs Total Operating Expenses Analysis

Interest Expense vs Total Operating Expenses

Interest Expense vs Total Operating Expenses Correlation Analysis

Correlation Coefficient

Interest Expense

Total Operating Expenses

Poly Medicure fundamental ratios Correlations

Poly Medicure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Poly Medicure fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Poly Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Retained Earnings	+ 1.0	Property Plant And Equipment Net
Non Current Assets Total	+ 0.99	Total Assets
Inventory	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets

Current Deferred Revenue	- 0.71	Non Current Liabilities Total
Current Deferred Revenue	- 0.55	Net Debt
Current Deferred Revenue	- 0.5	Short Long Term Debt Total
Cash	- 0.41	Net Debt
Current Deferred Revenue	- 0.25	Total Liab
Non Currrent Assets Other	- 0.23	Net Debt